Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tissue-specific genome engineering using CRISPR-Cas9

Tissue-specific genome engineering using CRISPR-Cas9

US Patent 10851367 · Granted Dec 1, 2020

Estimated economic value: $390,003,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant type V CRISPR/Cas effector polypeptides and methods of use thereof2025
CRISPR-Cas effector polypeptides and methods of use thereof2025
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNA2025
CRISPR-Cas effector polypeptides and methods of use thereof2025
CRISPR-Cas effector polypeptides and methods of use thereof2025
Methods and kits for identifying cancer treatment targets2025
Variant type V CRISPR/Cas effector polypeptides and methods of use thereof2025
Genetically engineered cells2025
Methods and kits for identifying cancer treatment targets2025
CasZ compositions and methods of use2025
RNA-guided nucleic acid modifying enzymes and methods of use thereof2025
Modulators of CAS9 polypeptides and methods of use thereof2025